Ascentage Pharma Group International - Unsponsored ADR (AAPG)

Last Closing Price: 24.40 (2025-05-30)

Net Income (Annual)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

Ascentage Pharma Group International - Unsponsored ADR (AAPG) had Net Income of $-55.54M for the most recently reported fiscal year, ending 2024-12-31.

Figures for fiscal year ending 2024-12-31
Income Statement Financials
$134.35M
Net Income
$-55.54M
$3.98M
$130.36M
$179.63M
$-45.28M
$-8.87M
$-54.15M
$-54.15M
$-55.58M
$-55.58M
$-55.58M
$-55.58M
$-45.28M
$-34.04M
75.52M
75.52M
$-0.72
$-0.72
Balance Sheet Financials
$201.96M
$116.37M
$156.68M
$358.64M
$159.82M
$121.85M
$161.25M
$321.08M
$37.56M
$23.77M
$37.56M
78.81M
Cash Flow Statement Financials
$-15.26M
$-49.60M
$43.12M
$142.21M
$122.35M
$-19.86M
$2.87M
--
--
Fundamental Metrics & Ratios
1.26
--
--
0.76
6.09
97.03%
-33.70%
-33.70%
-25.34%
-40.30%
-41.34%
$-18.58M
--
--
--
0.37
4.41
11.80
30.94
-147.97%
-233.86%
-15.50%
-34.86%
$0.48
$-0.25
$-0.20